TD Asset Management
BMY.RT

TD Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

TD Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-225,742
Closed -$156K – 1592
2020
Q4 		$156K Hold
225,742
– – ﹤0.01% 1425
2020
Q3 		$508K Buy
225,742
+2,500
+1% +$7.14K ﹤0.01% 1239
2020
Q2 		$799K Buy
223,242
+22,700
+11% +$81.9K ﹤0.01% 1110
2020
Q1 		$762K Buy
200,542
+6,500
+3% +$21.4K ﹤0.01% 1066
2019
Q4 		$584K Buy
+194,042
New +$505K ﹤0.01% 1210

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

TD Asset Management's BMY.RT Position: Q1 2021 in Review

TD Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 225,742 shares — an estimated $156K sold.

TD Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $799K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • TD Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • TD Asset Management sold 225,742 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $156K.
  • TD Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • TD Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $799K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on TD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.